BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Everest Medicines' Partner Calliditas Announces Nefecon® as Sole FDA-Approved Treatment for Slowing IgA Nephropathy Kidney Decline

The FDA approval is for adults with primary IgAN who are at risk for disease progression, irrespective of proteinuria levels. Nefecon® is now a...

December 21, 2023 | News

Dx&Vx Partners with LG CNS to Develop Bio-Health Data Platform in South Korea

Dx&Vx recently announced on the 18th that it has signed a contract with LG CNS to jointly develop a bio-healthcare big data platform utilizing AI ...

December 21, 2023 | News

Roche's Navify Digital Solutions Earn High Ratings in KLAS Research

Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilita...

December 20, 2023 | News

ArisGlobal Introduces LifeSphere® NavaX™ - The Next-Generation Cognitive Computing Engine

NavaX will revolutionize the end-to-end Research and Development processes with the latest advanced technologies ArisGlobal, a market leader in Life Scien...

December 15, 2023 | News

Nona Biosciences and Pfizer Strike Global Deal for MSLN-Targeted ADC HBM9033

Under the terms of the agreement, Nona Biosciences will receive a total of up to $53 million in upfront and near-term payments, with the potentia...

December 15, 2023 | News

Clover Initiates Phase Ⅰ Clinical Trial for RSV Vaccine Candidate

Clover Biopharmaceuticals, Ltd.  a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save li...

December 13, 2023 | News

Inside the World of Cell Therapies: Illuminating the Future of Cancer Care

The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...

December 13, 2023 | News

Danaher Completes Acquisition of Abcam

The acquisition of Abcam for $24.00 per share in cash was implemented by way of a Court-sanctioned scheme of arrangement under the UK Companies A...

December 11, 2023 | News

Nona Biosciences Announces Collaboration with Evive Biotech to Accelerate Antibody Discovery

The collaboration brings together professional advantages of Nona Biosciences and Evive Biotech, aiming to accelerate the process of antibody discovery and...

December 11, 2023 | News

Merck Collaborates with Acceleration Consortium on Open-Sourcing AI-Driven Experimentation Planner

"The release and maintenance of open-source code for scientific discovery is imperative for the advancement of self-driving labs. This collaboration moves ...

December 07, 2023 | News

Thermo Fisher and Project HOPE Collaborate for Health Equity in Sub-Saharan Africa's HIV-Positive Youth.

Thermo Fisher Scientific Inc., the world leader in serving science, and Project HOPE, a leading global health and humanitarian organization, tod...

December 04, 2023 | News

China Pharma Completes Third-Party Testing for Dry Eye Therapeutic Device

According to a disclosure by the Shanghai Public Health Clinical Center on June 6, 2023, an epidemiological survey of DED showed that approximately 34...

November 30, 2023 | News

PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target

Collaboration focused on discovering oral inhibitors of protein-protein interaction (PPI) targets by leveraging PRISM BioLab's proprietary PepMetics®...

November 29, 2023 | News

Is Asia ready to be the next global biotech hub?

As outlined in Cytiva’s 2023 Global Biopharma Resilience Index, economies such as Singapore, South Korea, Japan and Australia, are able to pr...

November 28, 2023 | Opinion | By Prem Mandalapu, Commercial General Manager, ASEAN, Cytiva

Stay Connected